​

Funding Round

Post-IPO Equity - CARGO Therapeutics

Post-IPO Equity - CARGO Therapeutics

Investment Firm

Overview

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Announced Date

May 28, 2024

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

10

Investor Name
Participant InvestorEcoR1 Capital
Participant InvestorNovo Holdings
Participant InvestorT. Rowe Price
Participant InvestorThird Rock Ventures
Participant InvestorWellington Management

Round Details and Background

CARGO Therapeutics raised $110000000 on 2024-05-28 in Post-IPO Equity

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 01, 2023
Series A - CARGO Therapeutics
13-200.0M
Jan 01, 2022
Seed Round - CARGO Therapeutics
2-undefined
May 28, 2024
Post-IPO Equity - CARGO Therapeutics
12-110.0M

Recent Activity

There is no recent news or activity for this profile.